{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:47:11Z","timestamp":1790344031085,"version":"4.1.0"},"reference-count":65,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Ashley Martucci FOP Research Fund at The University of Pennsylvania"},{"name":"Radiant Hope Foundation"},{"name":"Center for Research in FOP and Related Disorders at The University of Pennsylvania"},{"name":"Isaac and Rose Nassau Professorship of Orthopaedic Molecular Medicine at The University of Pennsylvania"},{"name":"Cali-Weldon Professorship of FOP Research at The University of Pennsylvania"},{"name":"Ian Cali Distinguished Clinician\u2013Scientist at The University of Pennsylvania"},{"name":"Robert and Arlene Kogod Professorship in Geriatric Medicine at The Mayo Clinic"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Single case studies of extraordinary disease resilience may provide therapeutic insight into conditions for which no definitive treatments exist. An otherwise healthy 35-year-old man (patient-R) with the canonical pathogenic ACVR1R206H variant and the classic congenital great toe malformation of fibrodysplasia ossificans progressiva (FOP) had extreme paucity of post-natal heterotopic ossification (HO) and nearly normal mobility. We hypothesized that patient-R lacked a sufficient post-natal inflammatory trigger for HO. A plasma biomarker survey revealed a reduction in total matrix metalloproteinase-9 (MMP-9) compared to healthy controls and individuals with quiescent FOP. Whole exome sequencing identified compound heterozygous variants in MMP-9 (c.59C\u2009&amp;gt;\u2009T, p.A20V and c.493G\u2009&amp;gt;\u2009A, p.D165N). Structural analysis of the D165N variant predicted both decreased MMP-9 secretion and activity that were confirmed by enzyme-linked immunosorbent assay and gelatin zymography. Further, human proinflammatory M1-like macrophages expressing either MMP-9 variant produced significantly less Activin A, an obligate ligand for HO in FOP, compared to wildtype controls. Importantly, MMP-9 inhibition by genetic, biologic, or pharmacologic means in multiple FOP mouse models abrogated trauma-induced HO, sequestered Activin A in the extracellular matrix (ECM), and induced regeneration of injured skeletal muscle. Our data suggest that MMP-9 is a druggable node linking inflammation to HO, orchestrates an existential role in the pathogenesis of FOP, and illustrates that a single patient\u2019s clinical phenotype can reveal critical molecular mechanisms of disease that unveil novel treatment strategies.<\/jats:p>","DOI":"10.1093\/jbmr\/zjae029","type":"journal-article","created":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T09:46:38Z","timestamp":1708163198000},"page":"382-398","source":"Crossref","is-referenced-by-count":16,"title":["Matrix metalloproteinase-9 deficiency confers resilience in fibrodysplasia ossificans progressiva in a man and mice"],"prefix":"10.1093","volume":"39","author":[{"given":"Vitali","family":"Lounev","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery, The University of Pennsylvania Perelman School of Medicine , Philadelphia, PA 19104 ,","place":["United States"]},{"name":"The Center for Research in FOP and Related Disorders, The University of Pennsylvania Perelman School of Medicine , Philadelphia, PA 19104 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay C","family":"Groppe","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Texas A & M University College of Dentistry , Dallas, TX 75246-2013 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niambi","family":"Brewer","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, The University of Pennsylvania Perelman School of Medicine , Philadelphia, PA 19104 ,","place":["United States"]},{"name":"The Center for Research in FOP and Related Disorders, The University of Pennsylvania Perelman School of Medicine , Philadelphia, PA 19104 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3711-1121","authenticated-orcid":false,"given":"Kelly L","family":"Wentworth","sequence":"additional","affiliation":[{"name":"Department of Medicine , Division of Endocrinology and Metabolism, Zuckerberg San Francisco General Hospital, , San Francisco, CA 94143-0794 ,","place":["United States"]},{"name":"University of California , Division of Endocrinology and Metabolism, Zuckerberg San Francisco General Hospital, , San Francisco, CA 94143-0794 ,","place":["United States"]},{"name":"Department of Medicine, University of California , San Francisco, CA 94143-0794 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Smith","sequence":"additional","affiliation":[{"name":"\u0101shibio Incorporated , Brisbane, CA 94005 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqi","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, The University of Pennsylvania Perelman School of Medicine , Philadelphia, PA 19104 ,","place":["United States"]},{"name":"The Center for Research in FOP and Related Disorders, The University of Pennsylvania Perelman School of Medicine , Philadelphia, PA 19104 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Schomburg","sequence":"additional","affiliation":[{"name":"Institute for Experimental Endocrinology, Charite University Hospital , D-10115 Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Bhargava","sequence":"additional","affiliation":[{"name":"\u0101shibio Incorporated , Brisbane, CA 94005 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Al Mukaddam","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, The University of Pennsylvania Perelman School of Medicine , Philadelphia, PA 19104 ,","place":["United States"]},{"name":"The Center for Research in FOP and Related Disorders, The University of Pennsylvania Perelman School of Medicine , Philadelphia, PA 19104 ,","place":["United States"]},{"name":"Department of Medicine, The University of Pennsylvania Perelman School of Medicine , Philadelphia, PA 19104 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward C","family":"Hsiao","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California , San Francisco, CA 94143-0794 ,","place":["United States"]},{"name":"Division of Endocrinology and Metabolism , The Institute for Human Genetics, the Program in Craniofacial Biology, , San Francisco, CA 94143-0794 ,","place":["United States"]},{"name":"University of California , The Institute for Human Genetics, the Program in Craniofacial Biology, , San Francisco, CA 94143-0794 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen M","family":"Shore","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, The University of Pennsylvania Perelman School of Medicine , Philadelphia, PA 19104 ,","place":["United States"]},{"name":"The Center for Research in FOP and Related Disorders, The University of Pennsylvania Perelman School of Medicine , Philadelphia, PA 19104 ,","place":["United States"]},{"name":"Department of Genetics, The University of Pennsylvania Perelman School of Medicine , Philadelphia, PA 19104 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Pignolo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mayo Clinic College of Medicine, Mayo Clinic , Rochester, MN 55905 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick S","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, The University of Pennsylvania Perelman School of Medicine , Philadelphia, PA 19104 ,","place":["United States"]},{"name":"The Center for Research in FOP and Related Disorders, The University of Pennsylvania Perelman School of Medicine , Philadelphia, PA 19104 ,","place":["United States"]},{"name":"Department of Medicine, The University of Pennsylvania Perelman School of Medicine , Philadelphia, PA 19104 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"issue":"2","key":"2025052403510798900_ref1","first-page":"437","article-title":"Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons","volume":"10 Suppl 2","author":"Pignolo","year":"2013","journal-title":"Pediatr Endocrinol Rev"},{"issue":"2","key":"2025052403510798900_ref2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2106\/00004623-199302000-00009","article-title":"The histopathology of fibrodysplasia ossificans progressiva. An endochondral process","volume":"75","author":"Kaplan","year":"1993","journal-title":"J Bone Joint Surg Am"},{"issue":"3","key":"2025052403510798900_ref3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/jbmr.2728","article-title":"The natural history of flare-ups in fibrodysplasia ossificans progressiva (FOP): a comprehensive global assessment","volume":"31","author":"Pignolo","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2025052403510798900_ref4","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2106\/JBJS.I.00705","article-title":"Early mortality and cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva","volume":"92","author":"Kaplan","year":"2010","journal-title":"J Bone Joint Surg Am"},{"issue":"4","key":"2025052403510798900_ref5","first-page":"101","article-title":"Druggable targets, clinical trial design and proposed pharmacological management in fibrodysplasia ossificans progressiva. Expert opinion on orphan","volume":"8","author":"Pignolo","year":"2020","journal-title":"Drugs"},{"issue":"3","key":"2025052403510798900_ref6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/humu.20868","article-title":"Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1","volume":"30","author":"Kaplan","year":"2009","journal-title":"Hum Mutat"},{"issue":"5","key":"2025052403510798900_ref7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ng1783","article-title":"A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva","volume":"38","author":"Shore","year":"2006","journal-title":"Nat Genet"},{"issue":"303","key":"2025052403510798900_ref8","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac4358","article-title":"ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A","volume":"7","author":"Hatsell","year":"2015","journal-title":"Sci Transl Med"},{"issue":"50","key":"2025052403510798900_ref9","doi-asserted-by":"crossref","first-page":"15438","DOI":"10.1073\/pnas.1510540112","article-title":"Neofunction of ACVR1 in fibrodysplasia ossificans progressiva","volume":"112","author":"Hino","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2025052403510798900_ref10","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-02872-2","article-title":"Activin-dependent signaling in fibro\/adipogenic progenitors causes fibrodysplasia ossificans progressiva","volume":"9","author":"Lees-Shepard","year":"2018","journal-title":"Nat Commun"},{"key":"2025052403510798900_ref11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bone.2017.11.014","article-title":"Activin A amplifies dysregulated BMP signaling and induces chondro-osseous differentiation of primary connective tissue progenitor cells in patients with fibrodysplasia ossificans progressiva (FOP)","volume":"109","author":"Wang","year":"2018","journal-title":"Bone"},{"issue":"2","key":"2025052403510798900_ref12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2106\/JBJS.F.00472","article-title":"Hematopoietic stem-cell contribution to ectopic skeletogenesis","volume":"89","author":"Kaplan","year":"2007","journal-title":"J Bone Joint Surg Am"},{"issue":"22","key":"2025052403510798900_ref13","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122958","article-title":"NF-kappaB\/MAPK activation underlies ACVR1-mediated inflammation in human heterotopic ossification","volume":"3","author":"Barruet","year":"2018","journal-title":"JCI Insight"},{"issue":"6","key":"2025052403510798900_ref14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11914-019-00541-x","article-title":"Inflammation in fibrodysplasia ossificans progressiva and other forms of heterotopic ossification","volume":"17","author":"Matsuo","year":"2019","journal-title":"Curr Osteoporos Rep"},{"key":"2025052403510798900_ref15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116129","article-title":"ACVR1(R206H) extends inflammatory responses in human induced pluripotent stem cell-derived macrophages","volume":"153","author":"Matsuo","year":"2021","journal-title":"Bone"},{"key":"2025052403510798900_ref16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bone.2017.04.015","article-title":"A cumulative analogue joint involvement scale (CAJIS) for fibrodysplasia ossificans progressiva (FOP)","volume":"101","author":"Kaplan","year":"2017","journal-title":"Bone"},{"issue":"1","key":"2025052403510798900_ref17","article-title":"Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypes","volume":"14","author":"Pignolo","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"2025052403510798900_ref18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nbt.3514","article-title":"Analysis of 589,306 genomes identifies individuals resilient to severe Mendelian childhood diseases","volume":"34","author":"Chen","year":"2016","journal-title":"Nat Biotechnol"},{"issue":"11","key":"2025052403510798900_ref19","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1002\/jbmr.4711","article-title":"Functional testing of bone morphogenetic protein (BMP) pathway variants identified on whole-exome sequencing in a patient with delayed-onset fibrodysplasia ossificans progressiva (FOP) using ACVR1(R206H) -specific human cellular and zebrafish models","volume":"37","author":"Wentworth","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2025052403510798900_ref20","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/jbmr.4492","article-title":"Plasma-soluble biomarkers for fibrodysplasia ossificans progressiva (FOP) reflect acute and chronic inflammatory states","volume":"37","author":"Pignolo","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2025052403510798900_ref21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/dvg.20201","article-title":"Generation of a mouse with conditionally activated signaling through the BMP receptor, ALK2","volume":"44","author":"Fukuda","year":"2006","journal-title":"Genesis"},{"issue":"5","key":"2025052403510798900_ref22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127063","article-title":"Selective allosteric inhibition of MMP9 is efficacious in preclinical models of ulcerative colitis and colorectal cancer","volume":"10","author":"Marshall","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"2025052403510798900_ref23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.intimp.2014.08.002","article-title":"THP-1 cell line: an in vitro cell model for immune modulation approach","volume":"23","author":"Chanput","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"2025052403510798900_ref24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fphar.2018.00071","article-title":"Convenience versus biological significance: are PMA-differentiated THP-1 cells a reliable substitute for blood-derived macrophages when studying in vitro polarization?","volume":"9","author":"Tedesco","year":"2018","journal-title":"Front Pharmacol"},{"issue":"1","key":"2025052403510798900_ref25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1186\/s12885-015-1546-9","article-title":"M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide","volume":"15","author":"Genin","year":"2015","journal-title":"BMC Cancer"},{"key":"2025052403510798900_ref26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.compbiolchem.2018.09.008","article-title":"Comprehensive analysis of damage associated SNPs of MMP9 gene: a computational approach","volume":"77","author":"Bhatnager","year":"2018","journal-title":"Comput Biol Chem"},{"issue":"8","key":"2025052403510798900_ref27","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/jbmr.1637","article-title":"An Acvr1 R206H knock-in mouse has fibrodysplasia ossificans progressiva","volume":"27","author":"Chakkalakal","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2025052403510798900_ref28","article-title":"Dynamics of skeletal muscle-resident stem cells during myogenesis in fibrodysplasia ossificans progressiva. NPJ","volume":"7","author":"Stanley","year":"2022","journal-title":"Regen Med"},{"key":"2025052403510798900_ref29","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bone.2017.06.011","article-title":"The obligatory role of activin A in the formation of heterotopic bone in fibrodysplasia ossificans progressiva","volume":"109","author":"Alessi Wolken","year":"2018","journal-title":"Bone"},{"issue":"Pt 17","key":"2025052403510798900_ref30","first-page":"3929","article-title":"The bright and the dark sides of activin in wound healing and cancer","volume":"125","author":"Antsiferova","year":"2012","journal-title":"J Cell Sci"},{"key":"2025052403510798900_ref31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102314","article-title":"Activin-A in the regulation of immunity in health and disease","volume":"104","author":"Morianos","year":"2019","journal-title":"J Autoimmun"},{"issue":"6","key":"2025052403510798900_ref32","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/9467","article-title":"VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation","volume":"5","author":"Gerber","year":"1999","journal-title":"Nat Med"},{"key":"2025052403510798900_ref33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.matbio.2022.10.002","article-title":"The gelatinases, matrix metalloproteinases 2 and 9, play individual roles in skeleton development","volume":"113","author":"Kalev-Altman","year":"2022","journal-title":"Matrix Biol"},{"issue":"3","key":"2025052403510798900_ref34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0092-8674(00)81169-1","article-title":"MMP-9\/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes","volume":"93","author":"Vu","year":"1998","journal-title":"Cell"},{"issue":"14","key":"2025052403510798900_ref35","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1093\/hmg\/ddp191","article-title":"Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy","volume":"18","author":"Li","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"6","key":"2025052403510798900_ref36","first-page":"391","article-title":"Matrix metalloproteinase-9: many shades of function in cardiovascular disease","volume":"28","author":"Yabluchanskiy","year":"2013","journal-title":"Physiology (Bethesda)"},{"issue":"1","key":"2025052403510798900_ref37","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-016-0393-1","article-title":"Effects of matrix metalloproteinases on the fate of mesenchymal stem cells","volume":"7","author":"Almalki","year":"2016","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"2025052403510798900_ref38","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0092-8674(02)00754-7","article-title":"Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand","volume":"109","author":"Heissig","year":"2002","journal-title":"Cell"},{"issue":"5","key":"2025052403510798900_ref39","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/CIRCGENETICS.112.963082","article-title":"Matrix metalloproteinase-9 genotype as a potential genetic marker for abdominal aortic aneurysm","volume":"5","author":"Duellman","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"issue":"17","key":"2025052403510798900_ref40","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1101\/gad.815400","article-title":"Matrix metalloproteinases: effectors of development and normal physiology","volume":"14","author":"Vu","year":"2000","journal-title":"Genes Dev"},{"issue":"2","key":"2025052403510798900_ref41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tcb.2003.12.003","article-title":"Matrix remodeling during endochondral ossification","volume":"14","author":"Ortega","year":"2004","journal-title":"Trends Cell Biol"},{"issue":"9","key":"2025052403510798900_ref42","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/jbmr.2848","article-title":"Cellular hypoxia promotes heterotopic ossification by amplifying BMP signaling","volume":"31","author":"Wang","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2025052403510798900_ref43","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ajhg.2009.06.014","article-title":"Mutations in MMP9 and MMP13 determine the mode of inheritance and the clinical spectrum of metaphyseal anadysplasia","volume":"85","author":"Lausch","year":"2009","journal-title":"Am J Hum Genet"},{"issue":"10","key":"2025052403510798900_ref44","doi-asserted-by":"crossref","first-page":"104307","DOI":"10.1016\/j.ejmg.2021.104307","article-title":"Early clinical and radiological improvement in a young boy with metaphyseal anadysplasia type 2","volume":"64","author":"Bonilla-Fornes","year":"2021","journal-title":"Eur J Med Genet"},{"issue":"11","key":"2025052403510798900_ref45","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/jor.23216","article-title":"Location-dependent heterotopic ossification in the rat model: the role of activated matrix metalloproteinase 9","volume":"34","author":"Davis","year":"2016","journal-title":"J Orthop Res"},{"issue":"2","key":"2025052403510798900_ref46","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s11999-013-3325-8","article-title":"Osteogenic gene expression correlates with development of heterotopic ossification in war wounds","volume":"472","author":"Evans","year":"2014","journal-title":"Clin Orthop Relat Res"},{"issue":"19-20","key":"2025052403510798900_ref47","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1089\/ten.tea.2011.0007","article-title":"Matrix metalloproteinase-9 is a diagnostic marker of heterotopic ossification in a murine model","volume":"17","author":"Rodenberg","year":"2011","journal-title":"Tissue Eng Part A"},{"issue":"8","key":"2025052403510798900_ref48","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/ajmg.a.36023","article-title":"High MMP-9 activity levels in fragile X syndrome are lowered by minocycline","volume":"161A","author":"Dziembowska","year":"2013","journal-title":"Am J Med Genet A"},{"issue":"4","key":"2025052403510798900_ref49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.5603\/FHC.a2016.0022","article-title":"Doxycycline down-regulates matrix metalloproteinase expression and inhibits NF-kappaB signaling in LPS-induced PC3 cells","volume":"54","author":"Ogut","year":"2016","journal-title":"Folia Histochem Cytobiol"},{"issue":"4","key":"2025052403510798900_ref50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174853","article-title":"Differential inhibition of activity, activation and gene expression of MMP-9 in THP-1 cells by azithromycin and minocycline versus bortezomib: a comparative study","volume":"12","author":"Vandooren","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"2025052403510798900_ref51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072121","article-title":"Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx mice","volume":"8","author":"Hindi","year":"2013","journal-title":"PLoS One"},{"issue":"11-12","key":"2025052403510798900_ref52","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1089\/ten.tea.2011.0459","article-title":"Decrease of MMP-9 activity improves soleus muscle regeneration","volume":"18","author":"Zimowska","year":"2012","journal-title":"Tissue Eng Part A"},{"issue":"2","key":"2025052403510798900_ref53","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/jbmr.3304","article-title":"Depletion of mast cells and macrophages impairs heterotopic ossification in anAcvr1R206HMouse model of fibrodysplasia ossificans progressiva","volume":"33","author":"Convente","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"47","key":"2025052403510798900_ref54","doi-asserted-by":"crossref","first-page":"36645","DOI":"10.1074\/jbc.M110.177865","article-title":"Activin a binds to perlecan through its pro-region that has heparin\/heparan sulfate binding activity","volume":"19","author":"Li","year":"2010","journal-title":"J Biol Chem"},{"issue":"2","key":"2025052403510798900_ref55","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1161\/01.RES.0000111527.42357.62","article-title":"Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues: potential role in capillary branching","volume":"94","author":"Johnson","year":"2004","journal-title":"Circ Res"},{"issue":"12","key":"2025052403510798900_ref56","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1242\/dev.121160","article-title":"Matrix metalloproteinase 9 modulates collagen matrices and wound repair","volume":"142","author":"LeBert","year":"2015","journal-title":"Development"},{"issue":"12","key":"2025052403510798900_ref57","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a005058","article-title":"Extracellular matrix degradation and remodeling in development and disease","volume":"3","author":"Lu","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"22","key":"2025052403510798900_ref58","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.260241","article-title":"Substrate adhesion determines migration during mesenchymal cell condensation in chondrogenesis","volume":"135","author":"Casanellas","year":"2022","journal-title":"J Cell Sci"},{"issue":"1","key":"2025052403510798900_ref59","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1091\/mbc.E18-05-0311","article-title":"ACVR1(R206H) FOP mutation alters mechanosensing and tissue stiffness during heterotopic ossification","volume":"30","author":"Haupt","year":"2019","journal-title":"Mol Biol Cell"},{"issue":"1","key":"2025052403510798900_ref60","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-17852-2","article-title":"Matrix stiffness and architecture drive fibro-adipogenic progenitors' activation into myofibroblasts","volume":"12","author":"Loomis","year":"2022","journal-title":"Sci Rep"},{"issue":"10","key":"2025052403510798900_ref61","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/jbmr.3760","article-title":"Elevated BMP and mechanical signaling through YAP1\/RhoA poises FOP mesenchymal progenitors for osteogenesis","volume":"34","author":"Stanley","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"3698","key":"2025052403510798900_ref62","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.150.3698.893","article-title":"Bone: formation by autoinduction","volume":"150","author":"Urist","year":"1965","journal-title":"Science"},{"issue":"5","key":"2025052403510798900_ref63","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00418-008-0391-1","article-title":"Exposure to pro-inflammatory cytokines upregulates MMP-9 synthesis by mesenchymal stem cells-derived osteoprogenitors","volume":"129","author":"Ben David","year":"2008","journal-title":"Histochem Cell Biol"},{"issue":"7","key":"2025052403510798900_ref64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040602","article-title":"Bone marrow-derived matrix metalloproteinase-9 is associated with fibrous adhesion formation after murine flexor tendon injury","volume":"7","author":"Loiselle","year":"2012","journal-title":"PLoS One"},{"issue":"6656","key":"2025052403510798900_ref65","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.ade6967","article-title":"In vivo hematopoietic stem cell modification by mRNA delivery","volume":"381","author":"Breda","year":"2023","journal-title":"Science"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmr\/advance-article-pdf\/doi\/10.1093\/jbmr\/zjae029\/57175006\/zjae029.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/39\/4\/382\/59922907\/zjae029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/39\/4\/382\/59922907\/zjae029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T07:51:28Z","timestamp":1748073088000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/39\/4\/382\/7609505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":65,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,2,16]]},"published-print":{"date-parts":[[2024,5,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmr\/zjae029","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4]]},"published":{"date-parts":[[2024,2,16]]}}}